Seer, Inc. (SEER) Financials
SEER Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2024-03-31 | 422.0 million | 38.4 million |
2023-12-31 | 436.3 million | 39.4 million |
2023-09-30 | 444.9 million | 39.2 million |
2023-06-30 | 461.2 million | 43.1 million |
SEER Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2024-03-31 | -11.2 million | 7.6 million |
2023-12-31 | -12.0 million | 7.6 million |
2023-09-30 | -18.6 million | 8.3 million |
2023-06-30 | -16.3 million | 9.8 million |
SEER Net Income
No data available :(
SEER Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2024-03-31 | 308.6 million | - | 27.7 million |
2023-12-31 | 316.2 million | - | 28.3 million |
2023-09-30 | 331.2 million | - | 28.8 million |
2023-06-30 | 320.2 million | - | 29.3 million |
SEER Shares Outstanding
SEER Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2024-03-31 | 754000 | 10.8 million | 14.3 million | - |
2023-12-31 | 1.8 million | 9.6 million | 13.1 million | - |
2023-09-30 | 4.2 million | 13.2 million | 14.8 million | - |
2023-06-30 | 1.1 million | 14.1 million | 16.1 million | - |
SEER Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2024-03-31 | 3.1 million | 3.2 million |
2023-12-31 | 4.2 million | 4.0 million |
2023-09-30 | 3.8 million | 2.0 million |
2023-06-30 | 3.5 million | 1.7 million |
SEER
Price: $1.77
52 week price:
Earnings Per Share: -1.35 USD
P/E Ratio: -1.17
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 150100
Market Capitalization: 129.5 million